Stock Screener App

無料 - Play StoreApp Store

インストールインストール

Dow:

Nasdaq:

S&P 500:

DVA

$187.503.01%-5.81

アフターアワーズ： 186.62-0.88 -0.47%

Davita Inc (DVA)

Date: O: H: L: C: Vol:

Davita Inc (DVA) 最新ニュース

DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y - Zacks Investment Research

DaVita earnings: what to look for from DVA - Yahoo Finance

DaVita settles ADA complaint with Lexington patient - WKYT

Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends? - Zacks Investment Research

Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends? - TradingView

DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks - PR Newswire

How Investors Are Reacting To DaVita (DVA) Kidney Week Research Push - Yahoo Finance

DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada

DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch

DaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to Know - Zacks Investment Research

DaVita Inc. Estimates – NYSE:DVA - TradingView

DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch

DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally? - Zacks Investment Research

DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally? - TradingView

DaVita Earnings Preview: What to Expect - Barchart.com

DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance

HHS Kidney Care Plan Raises Concerns for DaVita (DVA) Amid Positive Analyst Outlook - GuruFocus

DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice - PR Newswire

DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance

A Look at DaVita Inc (DVA) After 6.2% Decline -- GF Value $198.0 - GuruFocus

Why DaVita (DVA) Stock Is Nosediving - Yahoo Finance

Why DaVita (DVA) Stock Is Nosediving - TradingView

DaVita falls 6% amid proposed kidney care plan (DVA:NYSE) - Seeking Alpha

DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

HHS Launches Kidney Care National Plan, Impacting DaVita Inc (DV - GuruFocus

DaVita (DVA) Shares Slip Amid Trump Administration Dialysis Mark - GuruFocus

DaVita, Fresenius drop as HHS seeks dialysis market reforms (DVA:NYSE) - Seeking Alpha

DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call - The Napa Valley Register

DaVita $15 Million Data Breach Class Action Settlement - Claim Depot

DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call - DaVita Newsroom

DaVita HealthCare (DVA) Stock Moves -1.01%: What You Should Know - Zacks Investment Research

DaVita HealthCare (DVA) Stock Moves -1.01%: What You Should Know - Yahoo Finance

A Look at DaVita Inc (DVA) After 4.7% Gain -- GF Value $197.72 v - GuruFocus

DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch

Davita Brings New Clinical Research to Asn Kidney Week, Advancing Evidence for the Next Era of Kidney Care - www.marketscreener.com

Why patients miss dialysis is one focus of seven studies DaVita will present. - Stock Titan

DaVita Inc. (DVA) Stock forecasts - Yahoo Finance UK

Davita Inc Share Price - DVA, RNS News, Articles, Quotes, & Charts (NYSE:DVA) - Proactive financial news

DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada

DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance

DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch

DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Why DaVita HealthCare (DVA) Outpaced the Stock Market Today - Zacks Investment Research

DaVita rated Buy with 22% upside, driven by agg... - Pluang

DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again (NYSE:DVA) - Seeking Alpha

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Zacks Investment Research

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - TradingView

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Yahoo Finance

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - TradingView

DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

DVAに類似

ENSG$181.522.58%

EHC$135.903.35%

UHS$176.050.32%

PACS$47.813.76%

CHE$534.721.33%